The Study is Being Conducted to Evaluate the Efficacy and Safety of SHR-1316 in Combination With Chemo-radiotherapy in Patients With LS-SCLC.
Clinical trial NCT04691063 · UNKNOWN
Trial details
- NCT number
- NCT04691063
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-22
- Primary completion
- 2025-05-15
- Enrollment
- 486
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.